Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2009
Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors
Lixin Qiao, Sungwoon Choi, April Case, et al.
Cancer Cell
|
October 19, 2010
Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage
Xing Zeng, Frederic Sigoillot, Shantanu Gaur, et al.
Journal of Medicinal Chemistry
|
August 8, 2014
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants
Agustin H Mohedas, You Wang, Caroline E Sanvitale, et al.
Chemistry & Biology
|
October 3, 2003
Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line
Yichin Liu, Hilal A Lashuel, Sungwoon Choi, et al.
EMBO Molecular Medicine
|
June 7, 2013
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
Jonathan J Cherry, Erkan Y Osman, Matthew C Evans, et al.
Current Medicinal Chemistry
|
January 25, 2023
The Derivatives of Cromolyn Ameliorate the Abnormal Misfolding of Amyloid Proteins and Neuroinflammation in the Neural Cells
Joo-Hee Lee, Nivethasri Lakshmana Perumal, Sehee Kwon, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2017
Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers
Sungwoon Choi, Alyssa N Calder, Eliza H Miller, et al.
Journal of Medicinal Chemistry
|
May 9, 2017
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy
Anne Rietz, Hongxia Li, Kevin M Quist, et al.
Plos One
|
May 26, 2010
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin
Malcolm A Leissring, Enrico Malito, Sabrine Hedouin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2009
Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors
Lixin Qiao, Sungwoon Choi, April Case, et al.
Cancer Cell
|
October 19, 2010
Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage
Xing Zeng, Frederic Sigoillot, Shantanu Gaur, et al.
Journal of Medicinal Chemistry
|
August 8, 2014
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants
Agustin H Mohedas, You Wang, Caroline E Sanvitale, et al.
Chemistry & Biology
|
October 3, 2003
Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line
Yichin Liu, Hilal A Lashuel, Sungwoon Choi, et al.
EMBO Molecular Medicine
|
June 7, 2013
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
Jonathan J Cherry, Erkan Y Osman, Matthew C Evans, et al.
Current Medicinal Chemistry
|
January 25, 2023
The Derivatives of Cromolyn Ameliorate the Abnormal Misfolding of Amyloid Proteins and Neuroinflammation in the Neural Cells
Joo-Hee Lee, Nivethasri Lakshmana Perumal, Sehee Kwon, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2017
Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers
Sungwoon Choi, Alyssa N Calder, Eliza H Miller, et al.
Journal of Medicinal Chemistry
|
May 9, 2017
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy
Anne Rietz, Hongxia Li, Kevin M Quist, et al.
Plos One
|
May 26, 2010
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin
Malcolm A Leissring, Enrico Malito, Sabrine Hedouin, et al.
Page
of 2